window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotech

  • Biotech,Clinical Development,Clinical studies,Rare Diseases,Research & Development

    DEBRA Research and University Medical Center Groningen launch dedicated clinical trial site for Epidermolysis Bullosa

    DEBRA Research and the University Medical Center Groningen (UMCG) have [...]

    January 19, 2026
  • Biotech,Cell & Gene Therapy,Clinical Development,Clinical Trials,Opthalmology,Rare Diseases,Research & Development

    AAVantgarde completes enrollment in LUCE-1 Phase 1 and Phase 2 trial of gene therapy AAVB-081 for Usher syndrome type 1B

    AAVantgarde Bio has completed enrollment in LUCE-1, a first-in-human Phase [...]

    January 16, 2026
  • Artificial Intelligence,Biotech,Clinical Development,Clinical studies,Drug Development,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Immunai partners with Bristol Myers Squibb to apply immune system AI in clinical development

    Artificial Intelligence, Biotech, Clinical Development, Clinical studies, Drug Development, Partnerships [...]

    January 16, 2026
  • Biotech,Clinical Development,Drug Development,European biotech,Hematology,Research & Development,Respiratory

    Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk

    Cereno Scientific has published the first peer-reviewed paper describing its [...]

    January 16, 2026
  • Biotech,Clinical Development,Clinical studies,Clinical Trials,Healthcare leadership,Movers & Shakers,Rare Diseases

    Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth

    Veristat, a global clinical research organization (CRO) and consultancy specializing [...]

    January 15, 2026
  • Artificial Intelligence,Biotech,Drug Development,Mergers & Acquisitions,Technology and platforms

    CombinAbleAI to be acquired by insitro to expand AI drug discovery platform

    AI therapeutics company, insitro, has agreed to acquire CombinAbleAI in [...]

    January 14, 2026
  • Biomanufacturing,Biotech,CDMOs & Manufacturing,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Symeres welcomes Jurgen Berendsen as CFO to support global expansion

    Symeres has appointed Jurgen Berendsen as chief financial officer, strengthening [...]

    January 14, 2026
  • Biotech,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    BIA names Chris Molloy CEO to drive UK bioscience growth

    The BioIndustry Association (BIA) has appointed Chris Molloy as its [...]

    January 14, 2026
  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Clinical Development,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    iXCells names Steve Smith CEO to advance human iPSC preclinical services

    iXCells Biotechnologies has appointed Steve Smith as chief executive officer, [...]

    January 14, 2026
  • Biotech,Genetic Diseases,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics,Precision medicine

    Enhanced Genomics appoints Katerina Leftheris to board of directors

    Enhanced Genomics has appointed Katerina Leftheris to its board of [...]

    January 14, 2026
Previous567Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
  • Aravax adds allergy specialists to board as peanut therapy advances
    Categories: Biotech, Clinical Development, Clinical Trials, Healthcare leadership, Immunology, Movers & Shakers
  • AI-derived drug candidate reduces fentanyl intake in preclinical opioid study
    Categories: Artificial Intelligence, Clinical studies, Drug discovery, Neurosciences, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top